Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.67)
# 773
Out of 5,152 analysts
477
Total ratings
40.92%
Success rate
9.72%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $35 → $37 | $16.70 | +121.62% | 9 | Mar 2, 2026 | |
| VCEL Vericel | Maintains: Buy | $60 → $64 | $34.04 | +88.01% | 19 | Feb 27, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $34.07 | +76.11% | 29 | Feb 25, 2026 | |
| ECOR electroCore | Maintains: Buy | $25 → $18 | $7.55 | +138.41% | 14 | Jan 26, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintains: Buy | $102 → $130 | $90.76 | +43.23% | 5 | Jan 26, 2026 | |
| DCTH Delcath Systems | Reiterates: Buy | $30 | $9.01 | +232.96% | 16 | Jan 9, 2026 | |
| CGEN Compugen | Initiates: Buy | $4 | $2.01 | +99.00% | 1 | Jan 7, 2026 | |
| EKSO Ekso Bionics Holdings | Downgrades: Neutral | n/a | $11.31 | - | 17 | Dec 31, 2025 | |
| PYXS Pyxis Oncology | Maintains: Buy | $5 → $7 | $1.40 | +400.00% | 11 | Dec 19, 2025 | |
| ABSI Absci | Maintains: Buy | $7 → $8 | $2.55 | +214.34% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $13.79 | +226.32% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $17.27 | +108.45% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $3.13 | +538.98% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $156 → $54 | $6.03 | +795.61% | 8 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $99.60 | +55.62% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $113.66 | -17.30% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $9 | $3.32 | +171.49% | 14 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $14.27 | +124.25% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $8.36 | +55.60% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $47 | $60.27 | -22.02% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $3.56 | +40.45% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7,500 | $4.68 | +160,156.41% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.59 | +214.47% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.77 | +224.96% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.79 | +282.17% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.10 | +416.13% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.64 | +1,614.20% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $1.82 | +722.91% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.11 | +171.49% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.71 | +309.36% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.90 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.82 | +264.63% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.15 | -6.98% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.40 | +150.00% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $4.17 | +356.18% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $1.74 | +10,245.42% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $5.32 | +520.30% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $7.69 | +1,526.55% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $4.78 | +130.37% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.62 | +3,145.70% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.63 | +59.86% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.30 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.23 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.25 | +1,900.00% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.86 | +74.83% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.73 | +4,295.60% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.17 | +11,962.73% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.33 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $16.23 | -63.03% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.28 | +1,071.88% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $6.16 | +435.71% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $12.35 | -23.08% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $0.93 | +1,505,114.49% | 1 | Mar 5, 2020 |
Eton Pharmaceuticals
Mar 2, 2026
Maintains: Buy
Price Target: $35 → $37
Current: $16.70
Upside: +121.62%
Vericel
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $34.04
Upside: +88.01%
Corcept Therapeutics
Feb 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $34.07
Upside: +76.11%
electroCore
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $7.55
Upside: +138.41%
Mirum Pharmaceuticals
Jan 26, 2026
Maintains: Buy
Price Target: $102 → $130
Current: $90.76
Upside: +43.23%
Delcath Systems
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $9.01
Upside: +232.96%
Compugen
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.01
Upside: +99.00%
Ekso Bionics Holdings
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $11.31
Upside: -
Pyxis Oncology
Dec 19, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $1.40
Upside: +400.00%
Absci
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $2.55
Upside: +214.34%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $13.79
Upside: +226.32%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $17.27
Upside: +108.45%
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $3.13
Upside: +538.98%
Nov 18, 2025
Maintains: Buy
Price Target: $156 → $54
Current: $6.03
Upside: +795.61%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $99.60
Upside: +55.62%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $113.66
Upside: -17.30%
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $3.32
Upside: +171.49%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $14.27
Upside: +124.25%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $8.36
Upside: +55.60%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $60.27
Upside: -22.02%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $3.56
Upside: +40.45%
Nov 4, 2025
Assumes: Buy
Price Target: $7,500
Current: $4.68
Upside: +160,156.41%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.59
Upside: +214.47%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.77
Upside: +224.96%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.79
Upside: +282.17%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $3.10
Upside: +416.13%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.64
Upside: +1,614.20%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $1.82
Upside: +722.91%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.11
Upside: +171.49%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.71
Upside: +309.36%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.90
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.82
Upside: +264.63%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.15
Upside: -6.98%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.40
Upside: +150.00%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $4.17
Upside: +356.18%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $1.74
Upside: +10,245.42%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $5.32
Upside: +520.30%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $7.69
Upside: +1,526.55%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $4.78
Upside: +130.37%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.62
Upside: +3,145.70%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.63
Upside: +59.86%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.30
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.23
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.25
Upside: +1,900.00%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.86
Upside: +74.83%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.73
Upside: +4,295.60%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.17
Upside: +11,962.73%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $18.33
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $16.23
Upside: -63.03%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.28
Upside: +1,071.88%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $6.16
Upside: +435.71%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $12.35
Upside: -23.08%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $0.93
Upside: +1,505,114.49%